LAM IND Share Price Other OTC
Equities
US51280R1041
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
|
Sales 2019 | 15.56L 13Cr | Sales 2020 | - | Capitalization | 8L 6.75Cr |
---|---|---|---|---|---|
Net income 2019 | - 0 | Net income 2020 | - 0 | EV / Sales 2019 | 6.27 x |
Net Debt 2019 | 84.11L 70Cr | Net Debt 2020 | 24.82L 21Cr | EV / Sales 2020 | - |
P/E ratio 2019 |
-4.17
x | P/E ratio 2020 |
-4.29
x | Employees | - |
Yield 2019 * |
-
| Yield 2020 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Evan Karras
CEO | Chief Executive Officer | - | 30/15/30 |
Vince Demasi
COO | Chief Operating Officer | - | 20/18/20 |
Chief Tech/Sci/R&D Officer | - | 01/15/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Evan Karras
CEO | Chief Executive Officer | - | 30/15/30 |
John Guerra
SEC | Corporate Secretary | - | 31/13/31 |
Vince Demasi
COO | Chief Operating Officer | - | 20/18/20 |
1st Jan change | Capi. | |
---|---|---|
+23.61% | 12TCr | |
+22.68% | 2.75TCr | |
-18.07% | 2.09TCr | |
-13.99% | 1.7TCr | |
-14.81% | 1.63TCr | |
-46.10% | 1.51TCr | |
+9.78% | 1.46TCr | |
+52.34% | 1.39TCr | |
+143.76% | 1.22TCr |